NUPLAZID (pimavanserin) tablets, for oral use Initial U.S. Approval: 2016

Category: .

NUPLAZID (pimavanserin) tablets, for oral use Initial U.S. Approval: 2016

INDICATIONS AND USAGE
NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.
DOSAGE FORMS & STRENGTHS
Tablets: 17 mg
Manufactured By: ACADIA Pharmaceuticals Inc.
Prescribing Information URL: Click Here

Access to NUPLAZID ™ (pimavanserin) tablet: Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from Medvitaz Pharma Solutions.

Pimavanserin (ACP-103; BVF-036), sold under the brand name Nuplazid, is an atypical antipsychotic which is approved for the treatment of Parkinson's disease psychosis and is also being researched for the treatment of Alzheimer’s disease psychosis, schizophrenia, agitation, and major depressive disorder.

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.